Fintel on MSN4d
LifeSci Capital Initiates Coverage of Monte Rosa Therapeutics (GLUE) with Outperform RecommendationFintel reports that on March 12, 2025, LifeSci Capital initiated coverage of Monte Rosa Therapeutics (NasdaqGS:GLUE) with a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback